Navigation Links
AstraZeneca and the Sacramento County Pharmacy Provide Free Medicines to Eligible California Patients
Date:10/6/2010

WILMINGTON, Del., Oct. 6 /PRNewswire/ -- AstraZeneca (NYSE: AZN) announced today that it is providing medicines at no cost to qualifying patients at the Primary Care Center Pharmacy in Sacramento, California.

(Logo: http://photos.prnewswire.com/prnh/20091027/PH99766LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO)

AstraZeneca's partnership with the Sacramento County Pharmacy is an expansion of its AZ&Me™ Prescription Savings program that provides medicines at no cost to health facilities around the country. The Sacramento County Pharmacy is the ninth organization in California to join the program.

"The partnership with Sacramento County will help patients who might otherwise go without the medicines they need," said Jennifer McGovern, director, patient assistance programs, AstraZeneca Pharmaceuticals LP.

The Primary Care Center Pharmacy provides pharmaceuticals and medical supplies to nearly all departments within Sacramento County, dispensing an average of 1,200 prescriptions to patients per day.  Over the last eight years, the pharmacy's free drug programs have grown from one program with annual savings of $300,000 to 16 programs with annual savings in excess of $4.4 million. Approximately 25,000 uninsured patients benefit from the program.

"Working with AstraZeneca, the pharmacy will be able to get medicines to the people who need them, while focusing our resources on delivering programs and services to residents," said Steve Golka, director of pharmacy services, County of Sacramento.

Carrie's Touch, an organization that educates and empowers African-American women living with breast cancer in the Greater Sacramento area, praised the collaboration.

"I was fortunate enough to personally benefit from AZ&Me after losing my job and medical insurance," said Rev. Tammie Denyse, Carrie's Touch founder and president. "Without the support of this program, I would not have been able to receive my cancer medicine during this critical point in my treatment process. I am grateful this program exists."

Sacramento County Supervisor Roger Dickinson said, "AstraZeneca's commitment to providing free medicine is a crucial part of getting Sacramentans the care they need during tough economic times.  Many low-income workers don't have access to employer-sponsored health insurance and others lost coverage when they became unemployed during the recession.  Donated medicine ensures people get needed care and relieves financial pressure on an overburdened county health system."

In 2009, AstraZeneca provided more than $27.7 million in savings to more than 15,900 patients in California under its prescription savings programs – known as AZ&Me. Nationally, the company helped more than 507,000 patients save $769.6 million on their medicines.

About AZ&Me Prescription Savings Program for Healthcare Facilities

AZ&Me™ Prescription Savings program for healthcare facilities provides medicines free of charge to community free clinics, community health centers, hospitals and other qualifying facilities that serve the uninsured. The program is available to non-profit organizations that have a licensed outpatient pharmacy or dispensary on site and meet other program criteria. Patients are eligible for AstraZeneca medicines through this program if they do not have prescription drug coverage and have a household income at or below $30,000 for an individual or $60,000 for a family of four.

About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines.  As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of $32.8 billion in 2009. In the United States, AstraZeneca is a $14.8 billion healthcare business.

For more information about AstraZeneca in the US or our AZ&Me™ Prescription Savings programs, please visit www.astrazeneca-us.com or call 1-800-AZandMe (292-6363). 


'/>"/>
SOURCE AstraZeneca
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AstraZeneca Joins Rochester Initiative to Further Cardiac Safety
2. AstraZeneca and Grace Hill Neighborhood Health Centers, Inc. Provide Medicines to Missouris Uninsured
3. Silence Therapeutics and AstraZeneca Extend siRNA Development Collaboration
4. FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZenecas SYMBICORT
5. AstraZeneca to Support Drug-Induced Liver Injury Network at the National Institutes of Health
6. AstraZeneca Donates $1 Million for Christiana Care Health Systems Wilmington Hospital Project
7. Remarks as Prepared for Delivery By Attorney General Eric Holder at the AstraZeneca Settlement Announcement
8. Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-Label Drug Marketing
9. Palatin Technologies, Inc. Receives $2.5 Million from AstraZeneca
10. AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma
11. AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, ... anti-obesity drugs market is expected to grow at a CAGR ... CAGR of 38.7% in the second half of the forecast period. ... from 2016 to 2027. The market is estimated at $1,058 million ... ...
(Date:1/19/2017)... , January 19, 2017 ... European Oncology & Haematology, 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... Published recently in a supplement ... journal from touchONCOLOGY, an article by James ...
(Date:1/19/2017)...   Science Exchange , the leading marketplace ... the first five replication studies from the ... in eLife today. Despite intense scrutiny around reproducibility ... evaluation of reproducibility rates that may identify specific ... assessments of reproducibility, the results of this project ...
Breaking Medicine Technology:
(Date:1/20/2017)... Raton, FL (PRWEB) , ... January 20, 2017 , ... ... development, announced it attended the January ECRM trade show to continue the marketing and ... advanced vitamin C supplement, known for providing 400 percent better absorption than traditional vitamin ...
(Date:1/20/2017)... ... January 20, 2017 , ... Lice Troopers, the lice ... in families with school-aged children since the holiday season. , “It happens every ... their families, sharing hugs and taking photos, which is the head-to-head gateway that lice ...
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... highest level of nutritional and bodybuilding supplements, announced it attended the January ECRM trade ... a respected bodybuilder and nutritional scientist who was determined to create a line of ...
(Date:1/20/2017)... ... January 20, 2017 , ... "TransFlare 4K Mystique comes with 44 ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... Dragon Sensor,TransFlare 4K Mystique lens flare and light leak transitions have a very high-dynamic ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is ... life of the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater ... spent her career as an educator interacting with countless women who had little knowledge ...
Breaking Medicine News(10 mins):